Controlled substances: drug paraphernalia; definition of drug paraphernalia; modify. Amends sec. 7451 of 1978 PA 368 (MCL 333.7451).
Summary
SB 399 amends Michigan’s Public Health Code definition of “drug paraphernalia” to create a specific exception for drug-checking products used to determine whether a controlled substance contains chemicals, toxic substances, or hazardous compounds at levels that could cause physical harm or death. The bill expressly states that these testing products include, but are not limited to, fentanyl testing strips. Under current law, items designed for testing or analyzing controlled substances can fall within the paraphernalia definition; this bill carves out an exemption for harm-reduction testing tools.
The practical effect is to narrow the scope of the state’s drug paraphernalia laws in sections 7453 to 7461 and section 7521 of the Public Health Code. By excluding fentanyl test strips and similar products from the paraphernalia definition, the bill would reduce legal risk for possession, distribution, or use of those items and make it easier for public health agencies, harm-reduction organizations, and others to provide them without treating them as contraband. The bill does not change the underlying controlled substances laws, but it changes how certain testing products are treated under Michigan law.
Impact
SB 399 would amend MCL 333.7451, the statute defining drug paraphernalia, by adding a new subsection that excludes testing products used to detect dangerous contaminants in controlled substances. This would affect enforcement and interpretation of the Public Health Code provisions governing drug paraphernalia, especially as applied to fentanyl test strips and similar drug-checking supplies. The bill’s impact would be felt by law enforcement, prosecutors, public health providers, harm-reduction groups, and people who use drugs, because the items covered by the exemption would no longer be treated as drug paraphernalia under the specified sections.
Sentiment
The available voting history suggests the bill was generally supported. It was reported favorably out of committee without amendment by a 10-0 vote and then passed the Senate on third reading by a 33-3 vote. That pattern indicates broad bipartisan acceptance of the bill’s harm-reduction purpose, with only limited opposition on the floor. No committee transcripts were provided, so the record here reflects support inferred primarily from the strong vote margins.
Contention
The main point of contention is the policy choice to exempt fentanyl testing strips and similar drug-checking products from the paraphernalia definition. Supporters appear to view the change as a public health measure that can prevent overdoses by allowing people to test for dangerous contaminants. Opponents, as reflected by the small number of negative Senate votes, may object on grounds that the exemption could be seen as facilitating drug use or weakening drug enforcement. The bill does not appear to have generated major controversy, but it does sit at the intersection of harm reduction and traditional drug-control policy.